Regulatory Science/The Science Board/Standard Development

• Regulatory Science
  • Outline of Regulatory Science
• Regulatory Science Research Administration
  • Recent Publications by PMDA Staff
• Regulatory Science Coordination
  • The Science Board
    • The 7th Term (FY2024, FY2025)
    • The 6th Term (FY2022, FY2023)
    • The 5th Term (FY2020, FY2021)
    • The 4th Term (FY2018, FY2019)
    • The 3rd Term (FY2016, FY2017)
    • The 2nd Term (FY2014, FY2015)
    • The 1st Term (FY2012, FY2013)
  • Measures for advanced science and technology
    • Subcommittee on Cell and Gene Therapy Products Produced in vivo
    • Subcommittee on Therapeutic Products Based on Extracellular Vesicles (EVs) Including Exosomes
    • Subcommittee on Microbiome
    • Subcommittee on AMR
    • Subcommittee on Rare Cancers
    • Subcommittee on Pharmaceuticals Development
    • Subcommittee on Placebo-controlled Studies
    • Subcommittee on Non-clinical Studies
    • Pharmaceuticals Subcommittee
    • Bio-products Subcommittee
    • Subcommittee on Software as a Medical Device Utilizing AI and Machine Learning
    • Subcommittee on Computer Simulation
    • Subcommittee on AI (Artificial Intelligence)
    • Subcommittee on Application of Numerical Analysis to Non-clinical Evaluation
    • Subcommittee on Evaluation of Medical Devices in Pediatric Use
    • Medical Devices Subcommittee
    • Subcommittee on Genome Editing
    • CPC (Cell Processing Center) Subcommittee
    • Cellular and Tissue-based Products Subcommittee
  • RS Projects Across Multi-Offices in PMDA
• Standard Development
  • Outline
  • Japanese Pharmacopoeia
    • JP Editions and Supplements
      • 18th Edition
      • 17th Edition
      • 16th Edition
      • 15th Edition
    • JP Drafts
    • JP Technical Information
    • JP FAQ
    • Pharmacopoeial Harmonization
      • PDG Stage 2 Official Inquiry
    • Meetings & Events
    • Public comments
      • Japanese Pharmacopoeia
  • Medical Device Standards